Chromoendoscopic surveillance in hereditary diffuse gastric cancer: An alternative to prophylactic gastrectomy?

Gut

Volumn 54, Issue 4, 2005, Pages 461-468

  Shaw, D ^a   Blair, V ^b   Framp, A ^a   Harawira, P ^c   McLeod, M ^c   Guilford, P ^d   Parry, S ^e   Charlton, A ^e   Martin, I ^b  

^a TAURANGA HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c Kimihauora Health Centre   (New Zealand)

^d UNIVERSITY OF OTAGO   (New Zealand)

^e MIDDLEMORE HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

UVOMORULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CHROMOENDOSCOPY; CLINICAL ARTICLE; ENDOSCOPY; FAMILIAL CANCER; FEMALE; GASTRECTOMY; GASTROSCOPY; GENE MUTATION; HUMAN; MALE; MEDICAL RECORD; PATHOLOGY; PRIORITY JOURNAL; PROPHYLAXIS; STOMACH BIOPSY; STOMACH CANCER; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; CADHERINS; CARCINOMA, SIGNET RING CELL; CONGO RED; FEMALE; GASTRECTOMY; GASTROSCOPY; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; MALE; METHYLENE BLUE; MIDDLE AGED; NEOPLASTIC SYNDROMES, HEREDITARY; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 15444373041     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2004.049171     Document Type: Article

References (30)

1. Jones E. Familial gastric cancer. N Z Med J 1964;63:287-96.
2. Guilford P, Hopkins J, Harrawa, et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998;392:402-5.
3. Guilford P, Hopkins J, Grady W, et al. E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Hum Mutat 1999;14:249-55.
4. Chun YS, Lindor NM, Smyrk TC, et al. Germline E-cadherin mutations: Is prophylactic gastrectomy indicated? Cancer 2001;92:181-7.
5. Huntsman DG, Carneiro F, Lewis FR, et al. Early gastric cancer in young asymptomatic carriers of germline E-cadherin mutations. N Engl J Med 2001;344:1904-9.
6. Lewis FR, Mellinger JD, Hayashi A, et al. Prophylactic total gastrectomy for familial cancer. Surgery 2001;130:612-19.
7. Liedman B. Symptoms after total gastrectomy on food intake, body composition, bone metabolism ana quality of life in gastric cancer patients-is reconstrustion of a reservoir worthwhile? Nutrition 1999;15:677-82.
8. Dacosta RS WB, Marcon NE. New optical technologies for earlier endoscopic diagnosis of premalignant gastrointestinal lesions. J Gastroenterol Hepatol 2002;17:S85-104.
9. Fennerty M. Tissue staining. Gastroenterol Clin North Am J 1994;4:297-331.
10. Yamashina M. A variant of early gastric carcinoma: histologic and histochemical studies of early signet ring cell carcinomas discovered beneath preserved surface epithelium. Cancer 1986;58:1333-9.
11. Tatsuta M, Okuda S, Tamura H, et al. Endoscopic diagnosis of early gastric cancer by the endoscopic congo red-methylene blue test. Cancer 1982;50:2956-00.
12. Tatsuta M, Okuda S, Taniguchi H, et al. Gross and histological types of early gastric carcinomas in relation to the acid-secreting area. Cancer 1979;47:317.
13. Ida K HY, Kawai K. In vivo staining of gastric mucosa. Endoscopy 1975;7:18-24.
14. Charlton A, Blair V, Shaw D, et al. Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone. Gut 2004;53:814-20.
15. Fennerty M, Sampliner R, McGee D, et al. Intestinal metaplasia of the stomach: identification by a selective mucosal staining technique. Gastrointest Endosc 1992;38:696-98.
16. Japanese Research Society for Gastric Cancer. Japanese Classification of Gastric Carcinoma. Tokyo: Kanehara and Co. Ltd, 1995.
17. Caldas C, Carneiro F, Lynch HT, et al. Familial gastric cancer: overview and guidelines for management. J Med Genet 1999;36:873-80.
18. Toth E, Sjolund K, Thorsson O, et al. Evaluation of gastric acid secretion at endoscopy with a modified Congo red test. Gastrointest Endosc 2002;56:254-9.
19. Steensma D. "Congo" Red: Out of Africa? Arch Pathol Lab Med 2001;125:250-2.
20. Tatsuta M, Okuda S, Tamura H, et al. Endoscopic determination of the extent of early ulcerated gastric cancer by the congo red test. Endoscopy 1982;14:41-4.
21. Iishi H, Tatsuta M, Okuda S. Diagnosis of simultaneous multiple gastric cancers by the endoscopic congo red-methylene blue test. Endoscopy 1988;20:78-82.
22. Acar O, Schwizer O, Hauri D. The use of congo red mapping and marking for delineating the antral-corpus boundary during gastric bladder augmentation and replacement. Br J Urol 1999;84:725-26.
23. MerckChemicalDatabase. Safety data sheet: congo red, catalouge No 105233. www.chemdat.de/mda/index.html.
24. Gray U, Ostby J, Kavlock R, et al. Gonadal effects of fetal exposure to the aza dye congo red in mice: infertility in female but not male offspring. Fundam Appl Toxicol 1992;19:411-22.
25. 32P-Postlabeling test for covalent DNA binding of chemicals in vivo: application to a variety of aromatic carcinogens and methylating agents. Carcinogenesis 1984;5:231-43.
26. Kornbrust D, Barfknecht T. Comparison of 7 azo dyes and their azo reduction products in the rat and hamster hepatocyte primary culture/DNA-repair assays. Mutat Res 1984;136:255-66.
27. Zenser T, Lakshmi V, Davis B. N-Glucuronidation of benzidine and its metabolites: role in bladder cancer. Drug Metab Dispos 1998;26:856-9.
28. Bos R, Koopman J, Theuws J, et al. The essential role of the intestinal flora in the toxification of orally administered benzidine-based dyes: internal exposure of rats to benzidine after intestinal azo reduction. Mutat Res 1987;181:327.
29. Pharoah P, Guilford P, Caldas C, et al. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 2001;121:1348-53.
30. Tsukuma H, Oshima A, Narahara H, et al. Natural history of early gastic cancer: a non-concurrent long term followup study. Gut 2000;47:618-21.